NuGen Medical Devices Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NGMDF research report →
About the company
NuGen Medical Devices Inc. is a specialized firm dedicated to pioneering and marketing advanced drug delivery solutions. The company's core offering comprises innovative needle-free injection devices and systems, designed for subcutaneous medication delivery across a broad spectrum of medical conditions and therapeutic applications.
- CEO
- Lin Liang
- IPO
- 2022
- Employees
- 5
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $3.55M
- P/E
- -0.46
- P/S
- 30.45
- P/B
- -0.33
- EV/EBITDA
- -4.86
- Div Yield
- 0.00%
- Gross Margin
- -172.13%
- Op Margin
- -2766.00%
- Net Margin
- -6647.15%
- ROE
- 99.20%
- ROIC
- -180.39%
- Revenue
- $257.74K · -74.48%
- Net Income
- $-7,819,789 · -49.64%
- EPS
- $-0.03 · -40.98%
- Op Income
- $-4,217,159
- FCF YoY
- 18.15%
- 52W High
- $0.05
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 1.56
- Avg Volume
- 1.90K
Get TickerSpark's AI analysis on NGMDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NGMDF coverage
Recent articles, reports, and earnings notes.
No research on NGMDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NGMDF report →Similar companies
Peers in the same neighborhood.